Europe And Asia
Our client is a global healthcare company specializing in the development and commercialization of allergy immunotherapy (AIT) products and services. More than 1,200 employees operate from their offices in 20 countries with a commercial distribution network in 75 countries.
The introduction of a new IT system was intended to improve production, specifically by facilitating the supply and delivery processes. However, the months following the implementation of that IT system have been characterized by operational disruptions and incorrect product deliveries. Manufacturing processes have been affected, to the extent that products needed to be recalled due to mislabeling.
When C&F became involved, we diagnosed the following complications: